Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMZ001 once-daily diclofenac gel for knee osteoarthritis pain
2024-517404-11-00Phase 3Completed
- Sponsor
- Amzell B.V.
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing AMZ001 once daily with Matching placebo once daily (2 arms). Primary endpoint: Change from baseline in WOMAC pain sub-score at week 2. Started Apr 2025; status: completed.
02
Drugs
diclofenac (AMZ001 formulation)
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2024-517404-11-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517404-11-00.